Etorwis - P is a dual-ingredient tablet formulation combining Etoricoxib (60mg) and Paracetamol (325mg) in a stable, uniform matrix. The formulation leverages advanced excipient compatibility testing to ensure optimal dissolution, disintegration, and bioavailability of both active pharmaceutical ingredients (APIs). The tablet’s composition is engineered for consistent content uniformity, with excipients selected to enhance mechanical strength, moisture resistance, and shelf-life stability. The combination of Etoricoxib, a selective COX-2 inhibitor, and Paracetamol provides synergistic analgesic and anti-inflammatory effects, making it a versatile option for pharmaceutical manufacturers. The formulation adheres to strict physicochemical specifications, including pH neutrality, disintegration time (<30 minutes), and dissolution efficiency (>80% in pH 6.8 media). The product is suitable for both domestic and international markets, with a focus on compliance with pharmacopeial standards and regulatory requirements.
Manufacturing Capability
Our manufacturing infrastructure is designed to meet the demands of pharmaceutical manufacturers requiring high-volume, high-quality production. The facility is equipped with state-of-the-art tablet compression machines, high-speed tableters, and advanced coating systems to ensure precision in dosage form development. Sterile processing capabilities are available for critical APIs, with dedicated cleanrooms maintaining ISO 7 and ISO 8 classifications. All manufacturing processes adhere to current Good Manufacturing Practices (cGMP) and are validated to ensure consistency, reproducibility, and compliance with pharmacopeial standards. The production line supports scalability, enabling seamless transitions from pilot batches to large-scale commercial runs. Quality systems include real-time monitoring, automated data collection, and traceability mechanisms to ensure batch integrity. The facility also complies with environmental sustainability protocols, minimizing waste and optimizing resource efficiency.
Available Strengths and Packaging
Composition: Etoricoxib 60mg + Paracetamol 325mg Tab
Packaging: 10x10 Blister
Etorwis - P is available in a fixed-dose combination of 60mg Etoricoxib and 325mg Paracetamol in a 10x10 blister pack format. The blister packaging ensures tamper-evident protection, moisture resistance, and ease of handling for pharmaceutical suppliers. The packaging is designed to meet international regulatory standards for stability, storage, and transportation, making it ideal for bulk supply and global distribution.
Contract Manufacturing / Third Party Manufacturing
As a trusted manufacturer, we offer comprehensive third-party manufacturing services, including private label production and contract manufacturing for pharmaceutical buyers. Our capabilities extend to full-service outsourcing, from API sourcing and formulation development to packaging and labeling. We support customization of dosage forms, excipient blends, and packaging formats to meet specific client requirements. Our team of formulation scientists and regulatory experts ensures compliance with global standards while delivering cost-effective, scalable solutions. Whether you require a single product line or a diversified portfolio, we provide end-to-end manufacturing support tailored to your business needs.
Quality Assurance
Our quality assurance framework is built on rigorous analytical validation, batch testing, and adherence to pharmaceutical quality standards. Every batch undergoes comprehensive testing for identity, purity, potency, and dissolution using high-performance liquid chromatography (HPLC), UV spectrophotometry, and other validated methods. Microbial contamination testing, heavy metal analysis, and particle size distribution assessments are conducted to ensure product safety and efficacy. We maintain detailed batch records, traceability logs, and deviation management systems to guarantee compliance with cGMP and ISO 9001 standards. All quality control processes are audited regularly by third-party agencies to ensure transparency and reliability for pharmaceutical suppliers and exporters.
Regulatory Compliance
Etorwis - P is manufactured in full compliance with global regulatory frameworks, including current Good Manufacturing Practices (cGMP), World Health Organization (WHO) guidelines, and ISO 9001:2015 quality management standards. The product meets pharmacopeial requirements for both Etoricoxib and Paracetamol, ensuring acceptance in international markets. Our facility is registered with regulatory authorities in key regions, including the FDA, EMA, and MHRA, enabling seamless export and global supply. We also maintain compliance with the ICH Q7 guidelines for API manufacturing and adhere to environmental regulations for waste management and emissions control. This robust compliance structure ensures that pharmaceutical manufacturers can confidently source Etorwis - P for domestic and international distribution.
Global Supply Capability
We provide reliable bulk supply capabilities to meet the demands of pharmaceutical exporters, distributors, and contract manufacturers. Our international distribution network spans key markets in Asia, Europe, Africa, and the Americas, supported by strategic partnerships and logistics providers. The facility is equipped for large-scale production, with capacity to handle bulk orders ranging from 10,000 to 500,000 units per batch. Our supply chain is designed for resilience, with redundant inventory systems, real-time tracking, and contingency planning to ensure uninterrupted delivery. We support both FOB and CIF terms, offering flexible shipping options to accommodate diverse buyer requirements. Our commitment to compliance, quality, and timely delivery positions us as a dependable partner for global pharmaceutical supply chains.
Why Choose Us
Pharmaceutical distributors, exporters, and contract manufacturing partners benefit from our expertise in high-quality formulation development, regulatory compliance, and scalable production. Our cGMP-certified facility ensures consistent product quality, while our global supply network enables efficient distribution to international markets. As a manufacturer and supplier, we prioritize transparency, offering full traceability, detailed documentation, and responsive customer support. Our ability to deliver bulk supply in compliance with WHO, FDA, and ISO standards makes us an ideal partner for businesses seeking reliable, cost-effective solutions. Whether you require private label manufacturing, contract production, or export-ready packaging, we provide tailored services to meet your operational and regulatory needs.
Bulk Supply Inquiry
For bulk supply inquiries, please contact our team at info@delwishealthcare.com.
FAQs
Is Etorwis - P compliant with cGMP and WHO standards?
Yes, our manufacturing process adheres to current Good Manufacturing Practices (cGMP) and meets World Health Organization (WHO) guidelines for pharmaceutical quality and safety.
Can Etorwis - P be customized for private label manufacturing?
Yes, we offer private label manufacturing services, allowing clients to brand the product under their own trademark while maintaining compliance with global regulatory standards.
What certifications does your facility hold?
Our facility is certified under ISO 9001:2015, cGMP, and WHO GMP, ensuring adherence to international quality and safety benchmarks.
What is the minimum order quantity for bulk supply?
We accommodate bulk orders starting from 10,000 units, with flexibility to scale production based on client requirements.
How does your packaging ensure product stability?
The 10x10 blister packaging provides moisture resistance, tamper-evidence, and protection against environmental factors, ensuring product stability during storage and transportation.
Can you support export to specific regions?
Yes, our global distribution network enables export to Asia, Europe, Africa, and the Americas, with compliance tailored to regional regulatory frameworks.
What quality control measures are in place for each batch?
Every batch undergoes rigorous testing, including HPLC analysis, dissolution testing, microbial contamination checks, and heavy metal analysis, to ensure product consistency and safety.
How do you ensure supply chain reliability?
We maintain redundant inventory systems, real-time tracking, and contingency planning to ensure uninterrupted delivery, supported by a robust logistics network.
Are there options for contract manufacturing beyond Etorwis - P?
Yes, we offer contract manufacturing services for a wide range of pharmaceutical products, including single and multi-ingredient formulations.
What is the lead time for production and delivery?
Lead times vary based on order volume and customization requirements. We provide detailed timelines upon request and prioritize timely delivery to meet client deadlines.
